Document is current
Any future updates will be listed below
-
Authors
Novak, Alison R. https://orcid.org/0000-0002-1397-7748
Bradley, Mary E. https://orcid.org/0000-0003-3010-7979
Kiser, Tyree H. https://orcid.org/0000-0001-7415-3999
Mueller, Scott W. https://orcid.org/0000-0003-1238-8199
- License Information
-
More Information
Article History
First Online: 26 March 2020
Compliance with Ethical Standards
:
: Tyree Kiser reports grants from CTSA Grant Number UL1 TR002535 during the conduct of the study; and grants from Astellas, grants from Allergan and grants from Pfizer outside the submitted work. Scott Mueller reports grants from NCATS/NIH CTSA Grant Number UL1 TR002535 which supports the Colorado Clinical and Translational Sciences Institute; from CSL Behring Investigator-Initiated Study, grants from Merck Investigator-Initiated Studies Program; all industry funding has been received by the institution that employs Dr. Mueller, and is outside the submitted work (unrelated to antifungal therapeutics). Alison Novak and Mary Bradley declare no conflicts of interest relevant to this manuscript.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
